Search Results
Infinity Series with Imugene Chairman Paul Hopper ASX: IMU
Talking Biotech With Paul Hopper - Leading ASX Executive Chairman
Imugene HER-Vaxx video ASX: IMU | AN EMERGING LEADER IN CANCER IMMUNO-ONCOLOGY
Imugene featured on Behind The Scenes with Host Laurence Fishburne.
Executive Chairman and Founder, Paul Hopper interviewed on The CEO Masterclass by Peter Switzer.
Paul Hopper on Sky News
Imugene CEO says FDA IND approval for PD1-Vaxx is 'huge news' for the company
Imugene CEO Leslie Chong presents at Wholesale Investor's Virtual Showcase July 2020
The stock of the day is Imugene (IMU)
Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
Paul Hopper's full interview on Ticker News leading up to the IPO of Radiopharm Theranostics ASX:RAD
Imugene CEO hails clinical milestone for HER-Vaxx cancer immunotherapy
